GL1X · GenesisL1 explorer

Research workbench

Crystal structure of SARS-cov-2 rbd in complex with antibody nt-193

Analyse Crystal structure of SARS-cov-2 rbd in complex with antibody nt-193 in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
7E5O
Type
protein
Length
621 residues
Chains
3
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Nt-193 heavy chain; Nt-193 light chain; Spike protein S1
UniProt
P0DTC2
Ligands
NAG
Pockets
7 · best druggability 0.75

Structure

x-ray diffraction · 3 distinct chains · 8% helix, 42% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
HNt-193 heavy chainprotein2204% helix, 50% strand—
LNt-193 light chainprotein2136% helix, 50% strand—
ASpike protein S1protein18814% helix, 24% strandP0DTC2

Ligands and binding sites

  • NAG · 2-acetamido-2-deoxy-beta-D-glucopyranose · sugar · 2 copies · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

7 pockets found on a 1 Å grid, 2 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
1670.750.9917empty
22270.540.7729empty
32250.480.7435empty
4650.420.8114empty
5810.380.7715empty

Interfaces

3 interfaces between chains.

  • H–L · 1913 Ų buried · 13 hydrogen bonds · protein-protein
  • L–A · 650 Ų buried · 10 hydrogen bonds · protein-protein
  • H–A · 560 Ų buried · 10 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 8 disulfide, 1 glycan (disulfide, N-glycosylation).

Compared structures

  • 7E5O · Crystal structure of SARS-CoV-2 RBD in complex with antibody NT-193 · the same entry in another collection · chain H against H, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.